Novo Nordisk & Lilly: Price Cuts on Weight Loss Drugs!

Novo Nordisk and Lilly are cutting prices on weight loss drugs like Ozempic, Wegovy, and Zepbound due to competition and agreements. Discounts now available for cash buyers and some Medicare/Medicaid recipients.

Novo Nordisk and Lilly’s drugs all job by targeting the GLP-1 hormone that manages cravings. The medications bring a retail price of $1,000 and up each month, though significant price cuts and rebates are readily available to bring the price down.

Lilly Responds to Cost Concerns

“Lowering the cost of Zepbound single-dose vials is one way we are replying to the crucial need for more economical choices,” Eli Lilly chief executive officer David Ricks said in a statement. “We remain committed to giving solutions that resolve the problem of persistent diseases for clients throughout the nation.”

Novo Nordisk’s Price Competition

The statement came just weeks after rival Novo Nordisk said it was supplying a two-month introductory cost of $199 a month for U.S.-based cash money buyers of its top-selling diabetic issues and weight loss medicines, Ozempic and Wegovy. Novo Nordisk additionally reduced the “standard” cost for existing cash money customers to $349 a month from $499. Those discounts made Novo Nordisk’s drugs price-competitive with Eli Lilly’s Zepbound.

The cost cuts followed both business got to an agreement with the Trump management to minimize the cost of pre-filled pens following year for Wegovy and Zepbound to $350 each month on the TrumpRx portal, trending down to $245 monthly over a two-year duration. The drugs will certainly additionally be readily available to some Medicare and Medicaid recipients for the therapy of weight loss for the very first time.

Zepbound Price Reduction

Eli Lilly on Monday introduced that it is lowering the cash money price of Zepbound single-dose vials in the U.S. The rate adjustment puts on the self-pay option offered through the LillyDirect pharmacy, the firm claimed. Individuals paying cash for the weight management medication can now obtain a starting dose of Zepbound vials for $299 monthly, below $349 monthly.